Angiogenesis inhibitors increase tumor stem cells

Por Chau, Cindy H., Figg, William D.
Publicado em 2012

Aflibercept in pediatric solid tumors: moving beyond the trap

Por Chau, Cindy H., Figg, William D.
Publicado em 2012

Challenges to improved therapeutics for metastatic castrate resistant prostate cancer: from recent successes and failures

Por Huang, Xuan, Chau, Cindy H, Figg, William D
Publicado em 2012

Structural studies reveal thalidomide's mechanism of action and clinical effects: crystal clear or clearly complexed?

Por Ley, Ariel M, Chau, Cindy H, Figg, William D
Publicado no Cancer Biol Ther (2015)

Validation of Analytical Methods for Biomarkers Employed in Drug Development

Por Chau, Cindy H., Rixe, Olivier, McLeod, Howard, Figg, William D.
Publicado em 2008

Precision Oncology Medicine: The Clinical Relevance of Patient Specific Biomarkers Used to Optimize Cancer Treatment

Por Schmidt, Keith T., Chau, Cindy H., Price, Douglas K., Figg, William D.
Publicado no J Clin Pharmacol (2016)

ANDROGEN RECEPTOR VARIATION AFFECTS PROSTATE CANCER PROGRESSION AND DRUG RESISTANCE

Por McCrea, Edel, Sissung, Tristan M., Price, Douglas K., Chau, Cindy H., Figg, William D.
Publicado no Pharmacol Res (2016)

Shared mechanism of teratogenicity of anti-angiogenic drugs identified in the chicken embryo model

Por Beedie, Shaunna L., Mahony, Chris, Walker, Heather M., Chau, Cindy H., Figg, William D., Vargesson, Neil
Publicado no Sci Rep (2016)

In vivo screening and discovery of novel candidate thalidomide analogs in the zebrafish embryo and chicken embryo model systems

Por Beedie, Shaunna L., Rore, Holly M., Barnett, Shelby, Chau, Cindy H., Luo, Weiming, Greig, Nigel H., Figg, William D., Vargesson, Neil
Publicado no Oncotarget (2016)

Dual Targeting of the Androgen Receptor and Hypoxia-Inducible Factor 1α Pathways Synergistically Inhibits Castration-Resistant Prostate Cancer Cells

Por Fernandez, Elena V., Reece, Kelie M., Ley, Ariel M., Troutman, Sarah M., Sissung, Tristan M., Price, Douglas K., Chau, Cindy H., Figg, William D.
Publicado no Mol Pharmacol (2015)

Anti-Cancer Properties of a Novel Class of Tetrafluorinated Thalidomide Analogs

Por Beedie, Shaunna L., Peer, Cody J., Pisle, Steven, Gardner, Erin R., Mahony, Chris, Barnett, Shelby, Ambrozak, Agnieszka, Gütschow, Michael, Chau, Cindy H., Vargesson, Neil, Figg, William D.
Publicado no Mol Cancer Ther (2015)

Effect of SLCO1B3 haplotype on testosterone transport and clinical outcome in Caucasian patients with androgen-independent prostatic cancer

Por Hamada, Akinobu, Sissung, Tristan, Price, Douglas K., Danesi, Romano, Chau, Cindy H., Sharifi, Nima, Venzon, David, Maeda, Kenji, Nagao, Keisuke, Sparreboom, Alex, Mitsuya, Hiroaki, Dahut, William L., Figg, William D.
Publicado em 2008

Phase II Study of Satraplatin and Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer: A Pharmacogenetic Assessment of Outcome and Toxicity

Por Figg, William D., Chau, Cindy H., Madan, Ravi A., Gulley, James L., Gao, Rui, Sissung, Tristan M., Spencer, Shawn, Beatson, Melony, Aragon-Ching, Jeanny, Steinberg, Seth M., Dahut, William L.
Publicado em 2013

Epidithiodiketopiperazines (ETPs) exhibit in vitro antiangiogenic and in vivo antitumor activity by disrupting the HIF-1α/p300 complex in a preclinical model of prostate cancer

Por Reece, Kelie M, Richardson, Emily D, Cook, Kristina M, Campbell, Tessa J, Pisle, Stephen T, Holly, Alesia J, Venzon, David J, Liewehr, David J, Chau, Cindy H, Price, Douglas K, Figg, William D
Publicado em 2014

Androgen Receptor CAG Repeat Length and TMPRSS2:ETS Prostate Cancer Risk: Results from the Prostate Cancer Prevention Trial

Por Figg, William D., Chau, Cindy H., Price, Douglas K., Till, Cathee, Goodman, Phyllis J., Cho, Yonggon, Varella-Garcia, Marileila, Reichardt, Juergen K.V., Tangen, Catherine M., Leach, Robin J., van Bokhoven, Adrie, Thompson, Ian M., Lucia, M. Scott
Publicado em 2014

Phase II clinical trial of cediranib in patients with metastatic castration-resistant prostate cancer

Por Dahut, William L., Madan, Ravi A., Karakunnel, Joyson J., Adelberg, David, Gulley, James L., Turkbey, Ismail B., Chau, Cindy H., Spencer, Shawn D., Mulquin, Marcia, Wright, John, Parnes, Howard L., Steinberg, Seth M., Choyke, Peter L., Figg, William D.
Publicado em 2013

Association of Androgen Metabolism Gene Polymorphisms with Prostate Cancer Risk and Androgen Concentrations: Results from the Prostate Cancer Prevention Trial

Por Price, Douglas K., Chau, Cindy H., Till, Cathee, Goodman, Phyllis J., Leach, Robin J., Johnson-Pais, Teresa L., Hsing, Ann W., Hoque, Ashraful, Parnes, Howard L., Schenk, Jeannette M., Tangen, Catherine M., Thompson, Ian M., Reichardt, Juergen K.V., Figg, William D.
Publicado no Cancer (2016)

Androgen Receptor CAG Repeat Length and Association with Prostate Cancer Risk: Results from the Prostate Cancer Prevention Trial

Por Price, Douglas K., Chau, Cindy H., Till, Cathee, Goodman, Phyllis J., Baum, Caitlin E., Ockers, Sandy B., English, Bevin C., Minasian, Lori, Parnes, Howard L., Hsing, Ann W., Reichardt, Juergen K. V., Hoque, Ashraful, Tangen, Catherine M., Kristal, Alan R., Thompson, Ian M., Figg, William D.
Publicado em 2010

Finasteride Concentrations and Prostate Cancer Risk: Results from the Prostate Cancer Prevention Trial

Por Chau, Cindy H., Price, Douglas K., Till, Cathee, Goodman, Phyllis J., Chen, Xiaohong, Leach, Robin J., Johnson-Pais, Teresa L., Hsing, Ann W., Hoque, Ashraful, Tangen, Catherine M., Chu, Lisa, Parnes, Howard L., Schenk, Jeannette M., Reichardt, Juergen K. V., Thompson, Ian M., Figg, William D.
Publicado no PLoS One (2015)

Differential Expression of OATP1B3 Mediates Unconjugated Testosterone Influx

Por Sissung, Tristan M., Ley, Ariel M., Strope, Jonathan D., McCrea, Edel M., Beedie, Shaunna, Peer, Cody J., Shukla, Suneet, van Velkinburgh, Jennifer, Reece, Kelie, Troutman, Sarah, Campbell, Tessa, Fernandez, Elena, Huang, Phoebe, Smith, Jordan, Thakkar, Nilay, Venzon, David J., Brenner, Stefan, Lee, Wooin, Merino, Maria, Luo, Ji, Jager, Walter, Price, Douglas K., Chau, Cindy H., Figg, William D.
Publicado no Mol Cancer Res (2017)